AP NEWS

Metered Dose Inhaler (MDI) Technology: 2-Day Seminar (London, United Kingdom - February 20-21, 2019) - ResearchAndMarkets.com

December 7, 2018

DUBLIN--(BUSINESS WIRE)--Dec 7, 2018--The “Metered Dose Inhaler (MDI) Technology” conference has been added to ResearchAndMarkets.com’s offering.

A comprehensive overview of MDIs including development, manufacture, regulation and market potential

This interactive seminar will provide a comprehensive overview of metered-dose inhaler technology. It will clarify the therapeutic targets and look at delivery technologies. Participants will gain a valuable insight into market potential and receive detailed information on the manufacturing process, quality and inspection requirements and the regulatory pathways to follow.

This seminar will be beneficial for those new to the area and those who require a refresher on the opportunities with this technology. The seminar format will include practical workshops and there will be plenty of opportunity for discussion with the trainer who has significant experience in this field.

Agenda

Programme Day One

Therapeutic targets

Very brief history Asthma COPD Other local CF Systemic Why? Why not? Key characteristics Particle size Why?

Markets

Disease distribution Historic Current Future Drivers Manufacture vs use International procurement - Double and triple counting Regulation Geographic differences Pricing vs cost vs market - vs product

Delivery technologies

Inhalation MDI DPI: unit dose, multi-dose, reservoir Nebuliser: energy source, SMI, other Other Oral Injectable - Nasal Cost considerations - Design Scale Investment Cost of goods Typical breakdown Sensitivities

Workshop

Ranking of competitive technologies for different opportunities

Programme Day Two

The MDI - overview

Hardware Valves Canister Actuators Sources Formulations Solution Suspensions Other

The MDI - manufacturing process

Process Single-stage Multi-stage Cold Flow Areas

The MDI - manufacturing equipment

Scale Lab Small Medium Large

The MDI - quality and inspection

Incoming Release

The MDI - other performance

Prime and re-prime Thermal

Challenges and opportunities for the MDI - development and technical

Performance Stability Compatibility Hardware availability Manufacturing processes/equipment

Challenges and opportunities for the MDI and DPI

Co-ordination Breath actuation Training Breath co-ordination Deposition Spacers Holding chambers Enhancements Changing therapeutic approaches Once daily Combinations

Workshop (including coffee break)

SWOT MDI vs multi-dose DPI SWOT MDI vs Soft Mist Inhaler

Regulation of inhalation products

Regulatory landscape (EU, US, RoW) Generic New combination New chemical entity Time to market Success rate Key expectations Changing environment Combination product approaches Human factors Bioequivalence

For more information about this conference visit https://www.researchandmarkets.com/research/qfxzrf/metered_dose?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181207005493/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Inhalers and Nebulisers,Respiratory Devices

KEYWORD: UNITED KINGDOM EUROPE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/07/2018 02:21 PM/DISC: 12/07/2018 02:21 PM

http://www.businesswire.com/news/home/20181207005493/en

AP RADIO
Update hourly